8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Treatment of latent tuberculosis infection is an important strategy to prevent tuberculosis disease. In the USA, three tests are used to identify latent tuberculosis infection: the tuberculin skin test (TST) and two IFN-γ release assays (T-SPOT.TB and QuantiFERON). To our knowledge, few large studies have compared all three tests among people at high risk of latent tuberculosis infection or progression to tuberculosis disease. We aimed to assess test agreement between IFN-γ release assays and TST to provide guidance on their use in important risk groups.

          Related collections

          Author and article information

          Journal
          Lancet Infect Dis
          The Lancet. Infectious diseases
          Elsevier BV
          1474-4457
          1473-3099
          January 2022
          : 22
          : 1
          Affiliations
          [1 ] Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: gtb9@cdc.gov.
          [2 ] Division of Tuberculosis Elimination, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
          [3 ] TB Control Program, Public Health-Seattle and King County, Seattle, WA, USA.
          [4 ] Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, NC, USA.
          [5 ] Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, USA.
          [6 ] Division of Global Public Health, School of Medicine, University of California, San Diego, CA, USA.
          [7 ] Denver Health and Hospital Authority, Denver, CO, USA.
          Article
          S1473-3099(21)00145-6 NIHMS1754436
          10.1016/S1473-3099(21)00145-6
          8712384
          34499863
          1b85bc35-909d-42cc-ab47-f94a5a68d270
          Copyright © 2022 Elsevier Ltd. All rights reserved.
          History

          Comments

          Comment on this article